SciELO - Scientific Electronic Library Online

 
vol.40 número2Análisis temático desde el Observatorio Métrico de Coronavirus de las investigaciones publicadas en PubMed índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Investigaciones Biomédicas

versión impresa ISSN 0864-0300versión On-line ISSN 1561-3011

Resumen

ROBLEJO BALBUENA, Hilda et al. Clinical-epidemiological characteristics of patients affected by COVID-19 residing in Havana. Rev Cubana Invest Bioméd [online]. 2021, vol.40, n.2, e1566.  Epub 01-Jun-2021. ISSN 0864-0300.

Introduction:

Havana city was the most complex territory at the national level facingthe first outbreak of COVID-19. Its condition of capital, the population density, the limited geographical delimitation between its municipalities, the high inter-municipal and inter-provincial flow of people, added to the fact that it is the province that receives the largest number of travelers from abroad, conferred particularities on this territory.

Objective:

To determine the main clinical-epidemiological characteristics of patients affected by COVID-19 living in Havana.

Methods:

An observational, analytical, cross-sectional study was carried out. The sample contained 431 patients, older than one year, with epidemiological discharge from the SARS-CoV-2 infection. To collect information, a questionnaire was applied through an interview.

Results:

The average age of the sample was 45 years. More than half of the cases evolved in a symptomatic way (not serious or serious). Fever was the most frequent clinical manifestation. The individuals included in the sample, with blood group O or with a background of asthma, showed less risk of presenting symptomatic forms of the disease.

Conclusions:

The results suggest that age is the main risk factor for developing symptomatic forms (not severe or severe) of COVID-19. On the contrary, blood group O and a history of asthma are protective factors for these forms of clinical evolution.

Palabras clave : coronavirus; COVID-19; SARS-CoV-2; clinical-epidemiologic characteristics.

        · resumen en Español     · texto en Español     · Español ( pdf )